BB2290 Molecular Biomedicine 7.5 credits

Molekylär biomedicin

Show course information based on the chosen semester and course offering:

Offering and execution

No offering selected

Select the semester and course offering above to get information from the correct course syllabus and course offering.

Course information

Content and learning outcomes

Course contents *

The role of the genome and the epigenome in medicine will be in focus, both in health and disease conditions. Current and upcoming technologies to analyse genetic and epigenomic features will be discussed. The impact of genome variation will be exemplified with cancer, rare and complex diseases. Strategies for diagnosis and treatment of the diseases are covered, such as gene and stem cell therapy. Diseases related to polymerization and structural changes of proteins such as Alzheimer's disease and prion conditions will also be addressed.

The following subjects will be covered during the course

Human Genome Organisation & Principles of Genetic Variation
Principles of Gene Regulation and Epigenetics
Disease-causing genetic variants
Single gene disorders
Multifactorial disorders
Genetic Approaches to Treating Disease, including gene and cell therapy
Cancer

Intended learning outcomes *

The course aims to provide students an understanding of the use of genome and epigenome information in medicine. The course will give an advanced introduction to epigenetics and its role in health and disease.

After completion of the course the student shall have

Knowledge and understanding to:

  • Account for genome variation and related regulatory mechanisms in the context of health and disease
  • Describe in detail and summarise single and complex gene disorders as well as explain biological mechanisms associated to cancer

Skills and abilities to:

  • Demonstrate critical reading skills in the context of scientific articles
  • Examine current genetic approaches/technologies to detect, treat diseases and the role of genetic variation in drug response, metabolism
  • Evaluate and choose appropriate approaches and technologies to diagnose a given disease and assess genetic treatment approaches in a given context

Values and approaches to:

  • Assess the functional impact of genetic and epigenetic variants in health and disease

All aims have to be fulfilled in order to pass the course. For higher grade (A-D) the student must demonstrate skills, abilities, values and approaches within the subject in a complex context.

Course Disposition

No information inserted

Literature and preparations

Specific prerequisites *

Introduction to biotechnology BB1010, Biochemistry BB1040, Cell biology BB1020, Molecular biotechnology BB1060, Bioinformatics DD2396 and Applied gene technology BB2250 or corresponding courses.

Recommended prerequisites

Introduction to biotechnology BB1010, Cellbiology BB1020, Biochemistry BB1100, Molecular biotechnology BB1060, Bioinformatics DD2396 and Applied gene technology BB2250.

Equipment

No information inserted

Literature

No information inserted

Examination and completion

Grading scale *

A, B, C, D, E, FX, F

Examination *

  • LAB1 - Laboratory work, 1.0 credits, Grading scale: P, F
  • SEM1 - Project seminar, 2.0 credits, Grading scale: P, F
  • TEN2 - Written Exam, 4.5 credits, Grading scale: A, B, C, D, E, FX, F

Based on recommendation from KTH’s coordinator for disabilities, the examiner will decide how to adapt an examination for students with documented disability.

The examiner may apply another examination format when re-examining individual students.

Other requirements for final grade *

Attendance to seminar work(s) is mandatory to pass the course.

Opportunity to complete the requirements via supplementary examination

No information inserted

Opportunity to raise an approved grade via renewed examination

No information inserted

Examiner

Pelin Sahlén

Further information

Course web

Further information about the course can be found on the Course web at the link below. Information on the Course web will later be moved to this site.

Course web BB2290

Offered by

CBH/Gene Technology

Main field of study *

Biotechnology

Education cycle *

Second cycle

Add-on studies

No information inserted

Ethical approach *

  • All members of a group are responsible for the group's work.
  • In any assessment, every student shall honestly disclose any help received and sources used.
  • In an oral assessment, every student shall be able to present and answer questions about the entire assignment and solution.

Supplementary information

Students are required to sign up at least two weeks in advance for examination.

The course is given provided at least seven students are admitted.